Pages that link to "Q34924612"

The following pages link to mTOR inhibition rescues osteopenia in mice with systemic sclerosis (Q34924612):

Displaying 27 items.

• ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans. (Q30274910) (← links)
• Fibrillin microfibrils in bone physiology (Q34495815) (← links)
• Re-tuning bone formation (Q34924694) (← links)
• mTORC1 Signaling Promotes Osteoblast Differentiation from Preosteoblasts (Q35668339) (← links)
• Cytokines TNF-α, IL-6, IL-17F, and IL-4 Differentially Affect Osteogenic Differentiation of Human Adipose Stem Cells. (Q37271152) (← links)
• Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases (Q37649641) (← links)
• Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition (Q38454084) (← links)
• Fibrillin-1 Regulates Skeletal Stem Cell Differentiation by Modulating TGFβ Activity Within the Marrow Niche. (Q38851482) (← links)
• A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice (Q40047502) (← links)
• Establishment of NF-κB sensing and interleukin-4 secreting mesenchymal stromal cells as an "on-demand" drug delivery system to modulate inflammation (Q42512841) (← links)
• mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression (Q42706139) (← links)
• Alcohol Inhibits Odontogenic Differentiation of Human Dental Pulp Cells by Activating mTOR Signaling. (Q43373035) (← links)
• Chronic High Dose Alcohol Induces Osteopenia via Activation of mTOR Signaling in Bone Marrow Mesenchymal Stem Cells. (Q48632064) (← links)
• Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis (Q46404769) (← links)
• Mechanical loading modulates heterotopic ossification in calcific tendinopathy through the mTORC1 signaling pathway (Q47993033) (← links)
• Mammalian target of rapamycin as a therapeutic target in osteoporosis (Q48187280) (← links)
• Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice (Q51308225) (← links)
• The Fas/Fap-1/Cav-1 complex regulates IL-1RA secretion in mesenchymal stem cells to accelerate wound healing. (Q52355407) (← links)
• Primary atopic disorders. (Q52651330) (← links)
• Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice. (Q55081996) (← links)
• Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter. (Q55304199) (← links)
• Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta. (Q64898667) (← links)
• Ophiopogonin D promotes bone regeneration by stimulating CD31hi EMCNhi vessel formation (Q89814227) (← links)
• IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells (Q90261456) (← links)
• Dendrobium officinale polysaccharides regulate age-related lineage commitment between osteogenic and adipogenic differentiation (Q91634539) (← links)
• Stem cell-based bone and dental regeneration: a view of microenvironmental modulation (Q92682410) (← links)
• Treating Titanium Particle-Induced Inflammation with Genetically Modified NF-κB Sensing IL-4 Secreting or Preconditioned Mesenchymal Stem Cells in Vitro (Q94547908) (← links)